Several studies have also shown that the elevated tumor biomarkers including carcinoembryonic antigen (CEA) and serum carbohydrate antigen 19 − 9 (CA19-9) levels are associated with invasive carcinoma in IPMNs [5]. The gene discussed is CEACAM5; the disease is invasive carcinoma.